vs
DELUXE CORP（DLX）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
Royalty Pharma plc的季度营收约是DELUXE CORP的1.2倍（$622.0M vs $535.2M），Royalty Pharma plc净利率更高（34.4% vs 2.2%，领先32.2%），Royalty Pharma plc同比增速更快（4.8% vs 2.8%），过去两年Royalty Pharma plc的营收复合增速更高（4.6% vs 0.0%）
德朗士公司是一家美国企业，提供支付处理、数据服务、票据与促销产品以及商户服务，业务分为B2B支付、数据、印刷和商户服务四大板块。截至2025年，公司为数百万中小企业和数千家金融机构提供服务，每年处理支付交易总额超2.8万亿美元，虽传统核心业务为票据印刷等印刷产品，如今支付与数据服务已成为核心板块。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
DLX vs RPRX — 直观对比
营收规模更大
RPRX
是对方的1.2倍
$535.2M
营收增速更快
RPRX
高出2.0%
2.8%
净利率更高
RPRX
高出32.2%
2.2%
两年增速更快
RPRX
近两年复合增速
0.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $535.2M | $622.0M |
| 净利润 | $12.0M | $214.2M |
| 毛利率 | 52.2% | — |
| 营业利润率 | 8.9% | 62.4% |
| 净利率 | 2.2% | 34.4% |
| 营收同比 | 2.8% | 4.8% |
| 净利润同比 | -5.0% | 2.9% |
| 每股收益（稀释后） | $0.25 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DLXRPRX
| Q4 25 | $535.2M | $622.0M | ||
| Q3 25 | $540.2M | $609.3M | ||
| Q2 25 | $521.3M | $578.7M | ||
| Q1 25 | $536.5M | $568.2M | ||
| Q4 24 | $520.6M | $593.6M | ||
| Q3 24 | $528.4M | $564.7M | ||
| Q2 24 | $537.8M | $537.3M | ||
| Q1 24 | $535.0M | $568.0M |
净利润DLXRPRX
| Q4 25 | $12.0M | $214.2M | ||
| Q3 25 | $33.7M | $288.2M | ||
| Q2 25 | $22.4M | $30.2M | ||
| Q1 25 | $14.0M | $238.3M | ||
| Q4 24 | $12.6M | $208.2M | ||
| Q3 24 | $8.9M | $544.0M | ||
| Q2 24 | $20.5M | $102.0M | ||
| Q1 24 | $10.8M | $4.8M |
毛利率DLXRPRX
| Q4 25 | 52.2% | — | ||
| Q3 25 | 53.9% | — | ||
| Q2 25 | 53.6% | — | ||
| Q1 25 | 52.4% | — | ||
| Q4 24 | 52.3% | — | ||
| Q3 24 | 53.3% | — | ||
| Q2 24 | 53.7% | — | ||
| Q1 24 | 53.0% | — |
营业利润率DLXRPRX
| Q4 25 | 8.9% | 62.4% | ||
| Q3 25 | 14.0% | 70.1% | ||
| Q2 25 | 11.7% | 36.3% | ||
| Q1 25 | 9.0% | 94.0% | ||
| Q4 24 | 9.0% | 60.9% | ||
| Q3 24 | 7.9% | — | ||
| Q2 24 | 11.0% | 50.2% | ||
| Q1 24 | 8.3% | -13.0% |
净利率DLXRPRX
| Q4 25 | 2.2% | 34.4% | ||
| Q3 25 | 6.2% | 47.3% | ||
| Q2 25 | 4.3% | 5.2% | ||
| Q1 25 | 2.6% | 41.9% | ||
| Q4 24 | 2.4% | 35.1% | ||
| Q3 24 | 1.7% | 96.3% | ||
| Q2 24 | 3.8% | 19.0% | ||
| Q1 24 | 2.0% | 0.8% |
每股收益（稀释后）DLXRPRX
| Q4 25 | $0.25 | $0.49 | ||
| Q3 25 | $0.74 | $0.67 | ||
| Q2 25 | $0.50 | $0.07 | ||
| Q1 25 | $0.31 | $0.55 | ||
| Q4 24 | $0.28 | $0.46 | ||
| Q3 24 | $0.20 | $1.21 | ||
| Q2 24 | $0.46 | $0.23 | ||
| Q1 24 | $0.24 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $36.9M | $618.7M |
| 总债务越低越好 | — | $9.0B |
| 股东权益账面价值 | $680.7M | $9.7B |
| 总资产 | $2.9B | $19.6B |
| 负债/权益比越低杠杆越低 | — | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资DLXRPRX
| Q4 25 | $36.9M | $618.7M | ||
| Q3 25 | $25.8M | $938.9M | ||
| Q2 25 | $26.0M | $631.9M | ||
| Q1 25 | $30.3M | $1.1B | ||
| Q4 24 | $34.4M | $929.0M | ||
| Q3 24 | $41.3M | $950.1M | ||
| Q2 24 | $23.1M | $1.8B | ||
| Q1 24 | $23.5M | $843.0M |
总债务DLXRPRX
| Q4 25 | — | $9.0B | ||
| Q3 25 | — | $8.9B | ||
| Q2 25 | — | $8.0B | ||
| Q1 25 | — | $7.6B | ||
| Q4 24 | — | $7.6B | ||
| Q3 24 | — | $7.6B | ||
| Q2 24 | — | $7.6B | ||
| Q1 24 | — | $6.1B |
股东权益DLXRPRX
| Q4 25 | $680.7M | $9.7B | ||
| Q3 25 | $664.1M | $9.6B | ||
| Q2 25 | $638.7M | $9.5B | ||
| Q1 25 | $622.5M | $9.8B | ||
| Q4 24 | $620.9M | $10.3B | ||
| Q3 24 | $612.7M | $10.3B | ||
| Q2 24 | $620.5M | $9.8B | ||
| Q1 24 | $608.4M | $9.9B |
总资产DLXRPRX
| Q4 25 | $2.9B | $19.6B | ||
| Q3 25 | $2.6B | $19.3B | ||
| Q2 25 | $2.5B | $18.3B | ||
| Q1 25 | $2.6B | $17.6B | ||
| Q4 24 | $2.8B | $18.2B | ||
| Q3 24 | $2.6B | $18.0B | ||
| Q2 24 | $2.7B | $17.7B | ||
| Q1 24 | $2.7B | $16.1B |
负债/权益比DLXRPRX
| Q4 25 | — | 0.92× | ||
| Q3 25 | — | 0.93× | ||
| Q2 25 | — | 0.84× | ||
| Q1 25 | — | 0.78× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 0.74× | ||
| Q2 24 | — | 0.78× | ||
| Q1 24 | — | 0.62× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $102.1M | $827.1M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | 8.53× | 3.86× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流DLXRPRX
| Q4 25 | $102.1M | $827.1M | ||
| Q3 25 | $67.1M | $702.6M | ||
| Q2 25 | $51.1M | $364.0M | ||
| Q1 25 | $50.3M | $596.1M | ||
| Q4 24 | $60.2M | $742.5M | ||
| Q3 24 | $67.9M | $703.6M | ||
| Q2 24 | $39.6M | $658.2M | ||
| Q1 24 | $26.6M | $664.6M |
自由现金流DLXRPRX
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $27.8M | — | ||
| Q1 25 | $24.3M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $46.7M | — | ||
| Q2 24 | $11.4M | — | ||
| Q1 24 | $6.1M | — |
自由现金流率DLXRPRX
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 5.3% | — | ||
| Q1 25 | 4.5% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 8.8% | — | ||
| Q2 24 | 2.1% | — | ||
| Q1 24 | 1.1% | — |
资本支出强度DLXRPRX
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 4.5% | — | ||
| Q1 25 | 4.8% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 4.0% | — | ||
| Q2 24 | 5.2% | — | ||
| Q1 24 | 3.8% | — |
现金转化率DLXRPRX
| Q4 25 | 8.53× | 3.86× | ||
| Q3 25 | 1.99× | 2.44× | ||
| Q2 25 | 2.28× | 12.06× | ||
| Q1 25 | 3.59× | 2.50× | ||
| Q4 24 | 4.77× | 3.57× | ||
| Q3 24 | 7.60× | 1.29× | ||
| Q2 24 | 1.94× | 6.45× | ||
| Q1 24 | 2.46× | 139.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DLX
| Services | $247.9M | 46% |
| B2B Payments | $76.3M | 14% |
| Datadrivenmarketingsolutions | $68.5M | 13% |
| Promotional Solutions Revenue | $60.9M | 11% |
| Treasurymanagementsolutions | $59.8M | 11% |
| Other | $17.3M | 3% |
| Other Web Based Solutions | $4.6M | 1% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
